Fri, Dec 26, 2014, 3:00 AM EST - U.S. Markets open in 6 hrs 30 mins

Recent

% | $
Quotes you view appear here for quick access.

ConocoPhillips Message Board

e7navy1999 270 posts  |  Last Activity: Dec 24, 2014 9:04 AM Member since: Jan 21, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Nasdaq listing of MDBX

    by damjana.bajc Oct 29, 2014 4:33 PM
    e7navy1999 e7navy1999 Oct 30, 2014 8:57 AM Flag

    I think you hit the nail on the head! The vapor appointment is significant

    Sentiment: Strong Buy

  • Reply to

    Earnings

    by e7navy1999 Oct 30, 2014 7:35 AM
    e7navy1999 e7navy1999 Oct 30, 2014 8:55 AM Flag

    We will not even mention the lowest in the industry 9.5 P/E and the near 5% kicking tail dividend that pays like clock work!

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Oct 30, 2014 7:35 AM Flag

    :-) Profit was $2.7 billion, or $2.17 per share, compared with $2.5 billion, or $2.00 per share in the 2013 third quarter.

    :-) ConocoPhillips had third-quarter oil and gas production from continuing operations, excluding Libya, of 1.473 million barrels oil equivalent per day (boed), up 25,000 boed from a year ago.

    Sentiment: Strong Buy

  • Reply to

    Article: Oil to drop to $70

    by jonathanjon5656 Oct 23, 2014 9:17 AM
    e7navy1999 e7navy1999 Oct 29, 2014 7:28 PM Flag

    http://finance.yahoo.com/news/calls-100-barrel-oil-show-124009359.html Oil to hit 100. $90 is most likely the best stable target price

    Sentiment: Strong Buy

  • Reply to

    Who Owns Organovo?

    by twojugglers Oct 28, 2014 9:21 PM
    e7navy1999 e7navy1999 Oct 29, 2014 5:21 PM Flag

    From Morning Star reports top ten MF holders: (two new funds picked up a combined 49,000 shares but one dropped 55k shares but still holds 2.2 million shares)

    SPDR® S&P Biotech ETF Premium 2,178,059 #$%$880 2.82 1.06 10/28/2014
    Fidelity® Select Biotechnology Portfolio Premium 1,402,617 0 1.79 0.12 08/31/2014
    Vanguard Total Stock Mkt Idx Premium 1,015,835 0 1.29 0 09/30/2014
    Vanguard Extended Market Idx Inv Premium 588,572 42,529 0.75 0.01 09/30/2014
    iShares Russell 2000 Growth Premium 450,577 7,515 0.58 0.05 10/28/2014
    Rydex Biotechnology Adv Premium 320,180 0 0.41 0.48 09/30/2014
    Fidelity Advisor® Biotechnology A Premium 244,983 0 0.31 0.11 08/31/2014
    Fidelity Spartan® Extended Mkt Index Inv Premium 201,943 0 0.26 0.01 08/31/2014
    CREF Stock Premium 184,209 0 0.23 0 08/31/2014
    iShares Micro-Cap Premium 157,544 1,308 0.20 0.12 10/28/2014

    Total: Top 10 funds Premium 6,744,519 -4,528 8.64

    Sentiment: Strong Buy

  • Reply to

    Pink Power

    by ournightowl Oct 29, 2014 11:14 AM
    e7navy1999 e7navy1999 Oct 29, 2014 11:47 AM Flag

    thanks for sharing owl

    Sentiment: Strong Buy

  • Reply to

    Fresh Patent Applications

    by twojugglers Oct 29, 2014 11:07 AM
    e7navy1999 e7navy1999 Oct 29, 2014 11:43 AM Flag

    Nice right owl. The vascular part is why I think ONVO will be $270-$277 in a few years..for sure in 13 years!

    Sentiment: Strong Buy

  • e7navy1999 e7navy1999 Oct 29, 2014 10:34 AM Flag

    hey owl, I got you beat by just 10 years. I think $270 - $277 is where ONVO will be as long as she does not get bought out by RHHBY before then.

    Sentiment: Strong Buy

  • Reply to

    ONVO Upcoming events

    by e7navy1999 Oct 29, 2014 9:58 AM
    e7navy1999 e7navy1999 Oct 29, 2014 10:07 AM Flag

    Sorry to triple post but: if I were in the shoes of ONVO HR Department I would use an event similar to this to scout new hires! ONVO has 9-10 6+-figure positions currently open for this exact group in attendance

    Sentiment: Strong Buy

  • Reply to

    ONVO Upcoming events

    by e7navy1999 Oct 29, 2014 9:58 AM
    e7navy1999 e7navy1999 Oct 29, 2014 10:02 AM Flag

    Join us in Boston this coming Fall to attend Cambridge Healthtech Institute's (CHI) 2nd Annual FAST: Functional Analysis & Screening Technologies Congress on November 17-19, 2014 and meet with a community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Delegates have the opportunity to share insights in interactive panel discussions and connect during networking breaks. View innovative technologies and scientific research revolutionizing early-stage drug discovery in the exhibit/poster hall.

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Oct 29, 2014 9:58 AM Flag

    Upcoming Events

    Functional Analysis and Screening Technologies Congress
    11 / 17 / 2014 - 11 / 19 / 2014 in Boston, MA

    KEYNOTE SPEAKERS:

    Geraldine HamiltonGeraldine A. Hamilton, Ph.D.
    Senior Staff Scientist, Wyss Institute for Biologically Inspired Engineering, Harvard University

    Jing LiJing Li, Ph.D.
    Director, Genomics and Phenotypic Screening, Merck

    Alan WellsAlan H. Wells, M.D., D.M.Sc.
    Vice Chair and Thomas J. Gill III Professor, Pathology, University of Pittsburgh

    John WikswoJohn P. Wikswo, Ph.D.
    Founding Director, Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, Vanderbilt University

    George ChurchGeorge Church, Ph.D.
    Professor, Health Sciences and Technology, Harvard and MIT; Founding Core Faculty Member, Wyss Institute for Biologically Inspired Engineering, Harvard University

    Anna CollénAnna Collén
    Director, Reagents and Assay Development, AstraZeneca

    Kristin FabreKristin Fabre, Ph.D.
    Scientific Program Manager, NCATS, National Institutes of Health

    Meir GlickMeir Glick, Ph.D.
    Head, In Silico Lead Discovery, Center for Proteomic Chemistry, Novartis

    Society of Tox, 54th Annual Meeting and Tox Expo
    03 / 21 / 2015 - 03 / 26 / 2015 in San Diego, CA

    Sentiment: Strong Buy

  • e7navy1999 e7navy1999 Oct 28, 2014 3:55 PM Flag

    up near 10% on no news. I know there is good news out there. My UPS guy said they already began extra holiday hours and hired some major additions to the facilities. USA economy is booming behind the scenes. The local school district issued a PO for converted/bought new 700 Natural Gas buses as well. money is out there

    Sentiment: Strong Buy

  • Reply to

    Share Price Predictions

    by e7navy1999 Oct 27, 2014 5:19 PM
    e7navy1999 e7navy1999 Oct 28, 2014 2:33 PM Flag

    I roughly figure what $22 means in onvo market cap vs the estimated profits for the first year on liver assays plus any royalties from new drug development. Not to mention any new KOL reports and partnerships announced. Roche is involved and RHHBY is international in a big way.

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Oct 28, 2014 11:15 AM Flag

    Today is a nice little sneak peek into what November will bring. Owl's golden egg is ready to HATCH!

    Sentiment: Strong Buy

  • Reply to

    Take-over rumors

    by e7navy1999 Oct 27, 2014 1:02 PM
    e7navy1999 e7navy1999 Oct 28, 2014 11:11 AM Flag

    only rumors still. I am guessing a brokerage like e-trade. It would be a great income stream for one of them. WPCS has little advertising about celery and the buyout would be a perfect match

    Sentiment: Strong Buy

  • Reply to

    GO GO ONVO!!!!!!!

    by ournightowl Oct 27, 2014 7:33 AM
    e7navy1999 e7navy1999 Oct 28, 2014 10:16 AM Flag

    The golden egg will hatch soon enough

    Sentiment: Strong Buy

  • e7navy1999 e7navy1999 Oct 28, 2014 10:09 AM Flag

    us longs have to think LONG term. Liver assays may someday be FDA approved for damaged liver graft replacements........ as well has the dozen other areas ONVO is working on: skin, eyes, breast, lung, bladder, ...and the list goes on and on. The assays for drug testing is just the beginning...similar to the first computer memory chip, the first DOS program, the first wheel. think long term. ONVO is the BIO-3D leader head and shoulders above the rest, patents, expertise, leadership. ONVO is the future of medicine. IMHO, one share of ONVO will be like one original share of Berkshire just a few years away

    Sentiment: Strong Buy

  • Reply to

    WPCS Investigated for Criminal Fraud???

    by micks_stock_shop Oct 28, 2014 5:56 AM
    e7navy1999 e7navy1999 Oct 28, 2014 9:34 AM Flag

    total spammer, absolute no truth behind this

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Oct 27, 2014 5:19 PM Flag

    How many of you think we will hit $22 next month? predictions one and all. feel free

    Sentiment: Strong Buy

  • Reply to

    Short interest

    by e7navy1999 Oct 27, 2014 10:33 AM
    e7navy1999 e7navy1999 Oct 27, 2014 4:09 PM Flag

    b nice to see a KOL report and the assay sale announced the same day or better back to back days

    Sentiment: Strong Buy

COP
70.13-0.92(-1.29%)Dec 24 1:02 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Amira Nature Foods Ltd.
NYSEWed, Dec 24, 2014 1:04 PM EST
21Vianet Group, Inc.
NASDAQWed, Dec 24, 2014 12:59 PM EST